Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP436066.RAcrNKX0TPg1YAcfmTrvd7pFhN287Ph2fCbvg9_Zj-0k0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP436066.RAcrNKX0TPg1YAcfmTrvd7pFhN287Ph2fCbvg9_Zj-0k0130_assertion type Assertion NP436066.RAcrNKX0TPg1YAcfmTrvd7pFhN287Ph2fCbvg9_Zj-0k0130_head.
- NP436066.RAcrNKX0TPg1YAcfmTrvd7pFhN287Ph2fCbvg9_Zj-0k0130_assertion description "[To evaluate the prognostic value of the catalytic subunit telomerase reverse transcriptase (hTERT), we analysed its expression by immunohistochemistry in 122 formalin-fixed lung tumours including 42 squamous cell carcinoma (SCC), 43 adenocarcinoma (ADC), 19 basaloid carcinoma (BC) and 18 small-cell lung carcinoma (SCLC) in comparison with detection of hTERT mRNA by in situ hybridisation and relative telomerase activity by TRAP assay in a subset of tumours.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP436066.RAcrNKX0TPg1YAcfmTrvd7pFhN287Ph2fCbvg9_Zj-0k0130_provenance.
- NP436066.RAcrNKX0TPg1YAcfmTrvd7pFhN287Ph2fCbvg9_Zj-0k0130_assertion evidence source_evidence_literature NP436066.RAcrNKX0TPg1YAcfmTrvd7pFhN287Ph2fCbvg9_Zj-0k0130_provenance.
- NP436066.RAcrNKX0TPg1YAcfmTrvd7pFhN287Ph2fCbvg9_Zj-0k0130_assertion SIO_000772 15026805 NP436066.RAcrNKX0TPg1YAcfmTrvd7pFhN287Ph2fCbvg9_Zj-0k0130_provenance.
- NP436066.RAcrNKX0TPg1YAcfmTrvd7pFhN287Ph2fCbvg9_Zj-0k0130_assertion wasDerivedFrom befree-2016 NP436066.RAcrNKX0TPg1YAcfmTrvd7pFhN287Ph2fCbvg9_Zj-0k0130_provenance.
- NP436066.RAcrNKX0TPg1YAcfmTrvd7pFhN287Ph2fCbvg9_Zj-0k0130_assertion wasGeneratedBy ECO_0000203 NP436066.RAcrNKX0TPg1YAcfmTrvd7pFhN287Ph2fCbvg9_Zj-0k0130_provenance.